HHS should protect payments to clinical trial participants

The HHS Office of Inspector General is seeking public comment on whether to protect payments to clinical trial participants, a move supported by research showing that compensating individuals—including those who use drugs—is essential for developing effective medical treatments.

This report comes from The Hill. The story centres on HHS should protect payments to clinical trial participants. Full coverage and background context is available at the original source. Readers seeking more detail on this developing topic are encouraged to follow updates from The Hill and related outlets covering this beat.